Sutton Wealth Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8
Closed -$426 1535
2022
Q4
$426 Hold
8
﹤0.01% 1517
2022
Q3
$448 Sell
8
-137
-94% -$9.06K ﹤0.01% 1483
2022
Q2
$10.5K Sell
145
-90
-38% -$6.7K ﹤0.01% 890
2022
Q1
$18.7K Buy
235
+91
+63% +$8.2K 0.01% 732
2021
Q4
$14.6K Buy
144
+3
+2% +$299 ﹤0.01% 819
2021
Q3
$13K Hold
141
﹤0.01% 823
2021
Q2
$14.4K Hold
141
0.01% 799
2021
Q1
$13.8K Hold
141
0.01% 783
2020
Q4
$10.9K Hold
141
﹤0.01% 786
2020
Q3
$10.4K Hold
141
0.01% 731
2020
Q2
$10.4K Hold
141
0.01% 698
2020
Q1
$8.14K Sell
141
-48
-25% -$3.34K 0.01% 709
2019
Q4
$14.8K Buy
189
+48
+34% +$3.54K 0.01% 713
2019
Q3
$9.64K Buy
+141
New +$9.47K 0.01% 793

Other funds holding USNA

Sutton Wealth Advisors's USNA Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Usana Health Sciences (USNA) in Q1 2023, closing a stake of 8 shares — an estimated $426 sold.

Sutton Wealth Advisors first reported a position in USNA in Q3 2019 and held it in 14 quarters. The position peaked at $18.7K in Q1 2022. 176 funds tracked by Wall St. Rank hold USNA as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Usana Health Sciences position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 8 Usana Health Sciences shares in Q1 2023, an estimated $426.
  • Sutton Wealth Advisors first reported a position in Usana Health Sciences in Q3 2019 and held it in 14 quarters.
  • Sutton Wealth Advisors's Usana Health Sciences position peaked at $18.7K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.